UNITED STATES OF AMERICA
The world’s largest market for pharmaceuticals, USA has always been on Torrent Pharma’s strategic radar. Torrent Pharma Inc., our subsidiary, serves the growing need of our products in the market and today we are ranked 10th amongst the US generic Indian Companies.
The company currently has 65 ANDA approvals with 28 approvals in pipeline. We also have 150 products under development. We aim to strengthen our position in the market by launching Ointments, Injectables and Specialty Oral Solids (Oncology) in the coming times.
Torrent has strengthened the US presence through acquisition of Bio-Pharm, Inc. (BPI) a generic pharmaceuticals and OTC Company, based in Levittown Pennsylvania, USA, which includes, its first overseas US FDA registered manufacturing facility.
To date, BPI has 10 approved ANDAs, 10 ANDAs under review at the FDA for itself and it’s partners and has an additional 17 products under development.